Neuroone Medical Technologies Corp (NMTC) — Capital Reinvestment Ratio

Latest as of December 2024: 0.12x

Neuroone Medical Technologies Corp (NMTC) has a Capital Reinvestment Ratio of 0.12x as of December 2024, meaning it reinvests 0% of its operating cash flow ($208.05K) in capital expenditures ($24.42K). See how leveraged is Neuroone Medical Technologies Corp's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.12x

Capex / Operating Cash Flow

Operating Cash Flow

$208.05K

USD

Capital Expenditures

$24.42K

USD

Data as of

Dec 2024

Most recent filing

Annual Capital Reinvestment Ratio for Neuroone Medical Technologies Corp (None–None)

Year-by-year Capital Reinvestment Ratio for Neuroone Medical Technologies Corp from None to None. For live market cap and broader valuation context, see NMTC stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow